Mikko Neuvonen

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Liquid Chromatography

Mass Spectrometry

Antiplatelet Therapy

St Segment Elevation Myocardial Infarction

Top Venues

Clinical pharmacology and therapeutics

Drug metabolism and disposition: the biological fate of chemicals

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Kreetta Hämäläinen, Päivi Hirvensalo, Mikko Neuvonen, Aleksi Tornio, Janne T Backman, Marko Lehtonen, Mikko Niemi
Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function. Clinical and translational science 17 (3) (2024)
Anssi J H Mykkänen, E Katriina Tarkiainen, Suvi Taskinen, Mikko Neuvonen, Maria Paile-Hyvärinen, Tuomas Olavi Lilius, Tuija Tapaninen, Kathrin Klein, Matthias Schwab, Janne T Backman, Aleksi Tornio, Mikko Niemi
Genome-Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP. Clinical pharmacology and therapeutics 115 (6) (2024)
Kreetta Hämäläinen, Päivi Hirvensalo, Mikko Neuvonen, Aleksi Tornio, Janne T Backman, Marko Lehtonen, Mikko Niemi
Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function. Clinical and translational science 17 (3) (2024)
Anssi J H Mykkänen, E Katriina Tarkiainen, Suvi Taskinen, Mikko Neuvonen, Maria Paile-Hyvärinen, Tuomas Olavi Lilius, Tuija Tapaninen, Kathrin Klein, Matthias Schwab, Janne T Backman, Aleksi Tornio, Mikko Niemi
Genome-Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP. Clinical pharmacology and therapeutics 115 (6) (2024)
Anssi J H Mykkänen, E Katriina Tarkiainen, Suvi Taskinen, Mikko Neuvonen, Maria Paile-Hyvärinen, Tuomas Olavi Lilius, Tuija Tapaninen, Kathrin Klein, Matthias Schwab, Janne T Backman, Aleksi Tornio, Mikko Niemi
Genome-Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP. Clinical pharmacology and therapeutics (2024)
Feng Deng, Kreetta Hämäläinen, Minna Lehtisalo, Mikko Neuvonen, Mikko Niemi
Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4. Clinical pharmacology and therapeutics (2024)
Matti K Itkonen, Aleksi Tornio, Mikko Neuvonen, Pertti J Neuvonen, Mikko Niemi, Janne T Backman
Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In Humans. Drug metabolism and disposition: the biological fate of chemicals 47 (4) (2019)
Helinä Kahma, Anne M Filppula, Terhi Launiainen, Jenni Viinamäki, Mikko Neuvonen, Eric A Evangelista, Rheem A Totah, Janne T Backman
Critical Differences between Enzyme Sources in Sensitivity to Detect Time-Dependent Inactivation of CYP2C8. Drug metabolism and disposition: the biological fate of chemicals 47 (4) (2019)
Helinä Kahma, Anne M Filppula, Mikko Neuvonen, E Katriina Tarkiainen, Aleksi Tornio, Mikko T Holmberg, Matti K Itkonen, Moshe Finel, Pertti J Neuvonen, Mikko Niemi, Janne T Backman
Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions . Drug metabolism and disposition: the biological fate of chemicals 46 (2) (2017)